Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial. [electronic resource]
Producer: 20050216Description: 577-80 p. digitalISSN:- 0268-3369
- Acute Disease
- Adult
- Antineoplastic Agents, Alkylating -- administration & dosage
- Combined Modality Therapy
- Female
- Graft vs Host Disease -- mortality
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Leukemia, Myeloid -- drug therapy
- Male
- Middle Aged
- Radiation Dosage
- Recurrence
- Retrospective Studies
- Survival Analysis
- Thiotepa -- administration & dosage
- Transplantation Conditioning
- Transplantation, Homologous
- Whole-Body Irradiation
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.